Article
Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 1 Jan 2019
Ikawa Yasuhiro, Fujiki Toshihiro, Nishimura Ryosei, Noguchi Kazuhiro, Koshino Eri, Fujiki Akiko, Fukuda Masaki, Kuroda Rie, Mase Shintaro, Araki Raita, Maeba Hideaki, Shiraki Kimiyasu, Yachie Akihiro
Abstract excerpt
Resistant herpes simplex virus type 1 (HSV-1) infection is sometimes fatal for immunocompromised patients. Here, we report 10-year-old girl receiving hematopoietic stem cell transplantation developed refractory HSV-1 infection, which was persisted to intermittent acyclovir (ACV) or foscarnet (FOS) administrations but was improved by continuous ACV administration. The isolates from the lesion were identified with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
